High Flow Nasal Cannula Market Size To Hit US$ 15,926.4 Million By 2030

The global high flow nasal cannula market size is expected to hit around USD 15,926.4 million by 2030 and progressing a CAGR of 11.3% over the forecast period 2022 to 2030.

High Flow Nasal Cannula Market Size 2017-2030

The on high flow nasal cannula Market, which provides a business strategy, research & development activities, concise outline of the market valuation, valuable insights pertaining to market share, size, supply chain analysis, competitive landscape and regional proliferation of this industry.

Download Free Sample@ https://www.precedenceresearch.com/sample/1254

Scope of the Report

Report Highlights	Details
Market Size	USD 15,926.4 Billion by 2030
Growth Rate	CAGR of 11.3% from 2021 to 2030
Base Year	2020
Forecast Period	2021 to 2030
Historic Data	2017 to 2020
Segments Covered	Product, Application, End-User, Sales Channel, Region

A recent report provides crucial insights along with application based and forecast information in the Global High flow nasal cannula Market. The report provides a comprehensive analysis of key factors that are expected to drive the growth of this market. This study also provides a detailed overview of the opportunities along with the current trends observed in the High flow nasal cannula market.

A quantitative analysis of the industry is compiled for a period of 10 years in order to assist players to grow in the market. Insights on specific revenue figures generated are also given in the report, along with projected revenue at the end of the forecast period.

Companies and Manufacturers Covered

The study covers key players operating in the market along with prime schemes and strategies implemented by each player to hold high positions in the industry. Such a tough vendor landscape provides a competitive outlook of the industry, consequently existing as a key insight. These insights were thoroughly analysed and prime business strategies and products that offer high revenue generation capacities were identified. Key players of the global High flow nasal cannula market are included as given below:

High flow nasal cannula Market Key Players

Armstrong Medical Ltd
Salter Labs Inc
ResMed, Inc.
Teleflex Inc
Vapotherm Inc.
Becton Dickinson, and Company
Smiths Medical
Flexicare Medical Ltd
Teijin Pharma Limited
TNI Medical AG
Fisher & Paykel Healthcare Limited
Hamilton Medical AG

Market Segments

By Product Type

Single heated tube
Nasal cannula
Active humidifier
Air blender

By Application

Acute Respiratory Failure
Chronic Obstructive Pulmonary Disease
Acute Heart Failure
Others

By End-user

Hospitals and clinics
Ambulatory care centers
Long-term care centers
Others

By Sales Channel

Direct Channel
Distribution Channel

By Geography

North America

U.S.
Canada

Europe

Germany
France
United Kingdom
Rest of Europe

Asia Pacific

China
Japan
India
Southeast Asia
Rest of Asia Pacific

Latin America

Brazil
Rest of Latin America

Middle East & Africa (MEA)

GCC
North Africa
South Africa
Rest of Middle East & Africa

Report Objectives

To define, describe, and forecast the global high flow nasal cannula market based on product, and region
To provide detailed information regarding the major factors influencing the growth of the market (drivers, opportunities, and industry-specific challenges)
To strategically analyze micromarkets1 with respect to individual growth trends, future prospects, and contributions to the total market
To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
To forecast the size of market segments with respect to four main regions—North America, Europe, Asia Pacific and the Rest of the World (RoW)2
To strategically profile key players and comprehensively analyze their product portfolios, market shares, and core competencies3
To track and analyze competitive developments such as acquisitions, expansions, new product launches, and partnerships in the high flow nasal cannula market

Table of Content

Chapter 1. Introduction

1.1. Research Objective
1.2. Scope of the Study
1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach
2.2. Data Product Types
2.3. Assumptions& Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. High Flow Nasal Cannula Market Variables and Scope

4.1. Introduction
4.2. Market Classification and Scope

Chapter 5. COVID 19 Impact on High Flow Nasal Cannula Market

5.1. Covid-19: High Flow Nasal Cannula Industry Impact
5.2. High Flow Nasal Cannula Business Impact Assessment: Covid-19
5.2.1. Services Challenges/Disruption
5.2.2. Market Trends and High Flow Nasal Cannula Opportunities in the COVID-19 Landscape for Major Markets
5.3. Strategic Measures against Covid-19
5.3.1. Government Support and Initiative to Combat Covid-19
5.3.2. Proposal for High Flow Nasal Cannula Market Players to deal with Covid-19 Pandemic Scenario

Chapter 6. High Flow Nasal Cannula Market Dynamics Analysis and Trends

6.1. Market Dynamics
6.1.1. Market Drivers
6.1.1.1. Ever-increasing number of respiratory disorders
6.1.1.2. Low cost of high-flow nasal cannula compared to low-flow oxygen delivery systems
6.1.2. Market Restraints
6.1.2.1. Low rate of adoption of modern healthcare applications in developing countries
6.1.3. Market Opportunities
6.1.3.1. Increasing popularity and uptake of heated humidified high-flow nasal cannulas

Chapter 7. Global High Flow Nasal Cannula Market: Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis
7.1.1.1. High Flow Nasal Cannula Market Revenue by Market Players (2017 - 2020)
7.1.1.2. High Flow Nasal Cannula Market Revenue Market Share by Market Players (2017 - 2020)
7.1.2. Key Organic/Inorganic Strategies Adopted by Players
7.1.2.1. Product Portfolio, Expansion, Geographic Expansion, Product Innovation
7.1.2.2. Merger and Acquisition, Collaboration and Partnerships
7.1.3. Market Players Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of End user

Chapter 8. Global High Flow Nasal Cannula Market, By Product Type

8.1. High Flow Nasal Cannula Market, by Product Type, 2017-2030
8.1.1. Single Heated Tube
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. Nasal cannula
8.1.2.1. Market Revenue and Forecast (2017-2030)
8.1.3. Active humidifier
8.1.3.1. Market Revenue and Forecast (2017-2030)
8.1.4. Air blender
8.1.4.1. Market Revenue and Forecast (2017-2030)

Chapter 9. Global High Flow Nasal Cannula Market, By End-user

9.1. High Flow Nasal Cannula Market, by End-user, 2017-2030
9.1.1. Hospitals and clinics
9.1.1.1. Market Revenue and Forecast (2017-2030)
9.1.2. Ambulatory care centers
9.1.2.1. Market Revenue and Forecast (2017-2030)
9.1.3. Long-term care centers
9.1.3.1. Market Revenue and Forecast (2017-2030)
9.1.4. Others
9.1.4.1. Market Revenue and Forecast (2017-2030)

Chapter 10. Global High Flow Nasal Cannula Market, By Application

10.1. High Flow Nasal Cannula Market, by Application, 2017-2030
10.1.1. Acute Respiratory Disorder
10.1.1.1. Market Revenue and Forecast (2017-2030)
10.1.2. Chronic Respiratory Disorder
10.1.2.1. Market Revenue and Forecast (2017-2030)
10.1.3. Acute Heart Failures
10.1.3.1. Market Revenue and Forecast (2017-2030)
10.1.4. Others
10.1.4.1. Market Revenue and Forecast (2017-2030)

Chapter 11. Global High Flow Nasal Cannula Market, By Sales Channel

11.1. High Flow Nasal Cannula Market, by Sales Channel, 2017-2030
11.1.1. Direct Channel
11.1.1.1. Market Revenue and Forecast (2017-2030)
11.1.2. Distribution Channel
11.1.2.1. Market Revenue and Forecast (2017-2030)

Chapter 12. Global High Flow Nasal Cannula Market, Regional Estimates and Trend Forecast

12.1. North America
12.1.1. Market Revenue Forecast by Product Type(2017-2030)
12.1.2. Market Revenue Forecast by End-user (2017-2030)
12.1.3. Market Revenue Forecast by Application (2017-2030)
12.1.4. Market Revenue Forecast by Sales Channel (2017-2030)
12.1.5. U.S
12.1.5.1. Market Revenue Forecast (2017-2030)
12.1.6. Canada
12.1.6.1. Market Revenue Forecast (2017-2030)
12.2. Europe
12.2.1. Market Revenue Forecast by Product Type (2017-2030)
12.2.2. Market Revenue Forecast by End-user (2017-2030)
12.2.3. Market Revenue Forecast by Application (2017-2030)
12.2.4. Market Revenue Forecast by Sales Channel (2017-2030)
12.2.5. UK
12.2.5.1. Market Revenue Forecast (2017-2030)
12.2.6. Germany
12.2.6.1. Market Revenue Forecast (2017-2030)
12.2.7. France
12.2.7.1. Market Revenue Forecast (2017-2030)
12.2.8. Rest of EU
12.2.8.1. Market Revenue Forecast (2017-2030)
12.3. Asia Pacific (APAC)
12.3.1. Market Revenue Forecast by Product Type (2017-2030)
12.3.2. Market Revenue Forecast by End-user (2017-2030)
12.3.3. Market Revenue Forecast by Application (2017-2030)
12.3.4. Market Revenue Forecast by Sales Channel (2017-2030)
12.3.5. China
12.3.5.1. Market Revenue Forecast (2017-2030)
12.3.6. India
12.3.6.1. Market Revenue Forecast (2017-2030)
12.3.7. Japan
12.3.7.1. Market Revenue Forecast (2017-2030)
12.3.8. Rest of APAC
12.3.8.1. Market Revenue Forecast (2017-2030)
12.4. LATAM
12.4.1. Market Revenue Forecast by Product Type (2017-2030)
12.4.2. Market Revenue Forecast by End-user (2017-2030)
12.4.3. Market Revenue Forecast by Application (2017-2030)
12.4.4. Market Revenue Forecast by Sales Channel (2017-2030)
12.4.5. Brazil
12.4.5.1. Market Revenue Forecast (2017-2030)
12.4.6. Rest of LATAM
12.4.6.1. Market Revenue Forecast (2017-2030)
12.5. Middle East and Africa (MEA)
12.5.1. Market Revenue Forecast by Product Type (2017-2030)
12.5.2. Market Revenue Forecast by End-user (2017-2030)
12.5.3. Market Revenue Forecast by Application (2017-2030)
12.5.4. Market Revenue Forecast by Sales Channel (2017-2030)
12.5.5. GCC
12.5.5.1. Market Revenue Forecast (2017-2030)
12.5.6. North Africa
12.5.6.1. Market Revenue Forecast (2017-2030)
12.5.7. South Africa
12.5.7.1. Market Revenue Forecast (2017-2030)
12.5.8. Rest of MEA
12.5.8.1. Market Revenue Forecast (2017-2030)

Chapter 13. Company Profiles

13.1. Armstrong Medical Ltd
13.1.1. Company Overview, Business Information, Regional Presence
13.1.2. Product Portfolio, Analysis
13.1.2.1. Product Details, Specification, Application
13.1.3. Revenue, Price, and Gross Margin (2017-2020)
13.1.4. Recent Developments and Strategies
13.2. Becton Dickinson, and Company
13.2.1. Company Overview, Business Information, Regional Presence
13.2.2. Product Portfolio, Analysis
13.2.2.1. Product Details, Specification, Application
13.2.3. Revenue, Price, and Gross Margin (2017-2020)
13.2.4. Recent Developments and Strategies
13.3. Fisher & Paykel Healthcare Limited
13.3.1. Company Overview, Business Information, Regional Presence
13.3.2. Product Portfolio, Analysis
13.3.2.1. Product Details, Specification, Application
13.3.3. Revenue, Price, and Gross Margin (2017-2020)
13.3.4. Recent Developments and Strategies
13.4. Flexicare Medical Ltd
13.4.1. Company Overview, Business Information, Regional Presence
13.4.2. Product Portfolio, Analysis
13.4.2.1. Product Details, Specification, Application
13.4.3. Revenue, Price, and Gross Margin (2017-2020)
13.4.4. Recent Developments and Strategies
13.5. Hamilton Medical AG
13.5.1. Company Overview, Business Information, Regional Presence
13.5.2. Product Portfolio, Analysis
13.5.2.1. Product Details, Specification, Application
13.5.3. Revenue, Price, and Gross Margin (2017-2020)
13.5.4. Recent Developments and Strategies
13.6. ResMed, Inc.
13.6.1. Company Overview, Business Information, Regional Presence
13.6.2. Product Portfolio, Analysis
13.6.2.1. Product Details, Specification, Application
13.6.3. Revenue, Price, and Gross Margin (2017-2020)
13.6.4. Recent Developments and Strategies
13.7. Salter Labs Inc
13.7.1. Company Overview, Business Information, Regional Presence
13.7.2. Product Portfolio, Analysis
13.7.2.1. Product Details, Specification, Application
13.7.3. Revenue, Price, and Gross Margin (2017-2020)
13.7.4. Recent Developments and Strategies
13.8. Smiths Medical
13.8.1. Company Overview, Business Information, Regional Presence
13.8.2. Product Portfolio, Analysis
13.8.2.1. Product Details, Specification, Application
13.8.3. Revenue, Price, and Gross Margin (2017-2020)
13.8.4. Recent Developments and Strategies
13.9. Teijin Pharma Limited.
13.9.1. Company Overview, Business Information, Regional Presence
13.9.2. Product Portfolio, Analysis
13.9.2.1. Product Details, Specification, Application
13.9.3. Revenue, Price, and Gross Margin (2017-2020)
13.9.4. Recent Developments and Strategies
13.10. Teleflex Inc
13.10.1. Company Overview, Business Information, Regional Presence
13.10.2. Product Portfolio, Analysis
13.10.2.1. Product Details, Specification, Application
13.10.3. Revenue, Price, and Gross Margin (2017-2020)
13.10.4. Recent Developments and Strategies
13.11. TNI Medical AG
13.11.1. Company Overview, Business Information, Regional Presence
13.11.2. Product Portfolio, Analysis
13.11.2.1. Product Details, Specification, Application
13.11.3. Revenue, Price, and Gross Margin (2017-2020)
13.11.4. Recent Developments and Strategies
13.12. Vapotherm Inc.
13.12.1. Company Overview, Business Information, Regional Presence
13.12.2. Product Portfolio, Analysis
13.12.2.1. Product Details, Specification, Application
13.12.3. Revenue, Price, and Gross Margin (2017-2020)
13.12.4. Recent Developments and Strategies